Business Wire

CA-ESRI

5.10.2021 15:02:11 CEST | Business Wire | Press release

Share
Esri Releases ArcGIS GeoBIM, Bringing Spatial Context to AEC Operations

Global construction challenges, from affordable housing availability to infrastructure stress as a result of climate change, have increased in recent years. As a result, governments and commercial organizations will need to invest trillions of dollars in the next decade in mitigation and recovery processes. By adopting building information modeling (BIM) and geographic information system (GIS) technology, the architecture, engineering, and construction (AEC) industry improved construction, design, and operations efficiency. Recognizing the benefits for project outcomes that a combined BIM and GIS software would present, Esri , the global leader in location intelligence, joined forces with Autodesk in 2017. The partnership produced new technology, integrating the power of mapping into the BIM process.

Today, Esri is releasing a new product that expands the ability for BIM project teams to benefit from GIS. ArcGIS GeoBIM provides an innovative, easy-to-use web-based experience for AEC teams to explore and collaborate using data from multiple systems in a geospatial context. ArcGIS GeoBIM connects to Autodesk BIM Collaborate Pro , a cloud-based design collaboration, coordination, and model coauthoring software built on the Autodesk Construction Cloud .

"With many global initiatives under way to improve construction, design, and planning practices, it is critical that today's AEC professionals can collaborate together with a common view of assets in a geospatial context," said Jack Dangermond, Esri founder and president. "The ability to operate without siloed data provides AEC professionals with the flexibility they need to work together and meet the challenges of building in the future on an unprecedented scale."

ArcGIS GeoBIM will provide project leaders and stakeholders in industries like infrastructure, construction, planning, water, and transportation with a common view of asset locations, costs, issues, risks, and timelines throughout the project life cycle.

"Autodesk and Esri's cloud-to-cloud connection gives our shared customers a unified experience and the information they need at their fingertips—regardless of whether it's BIM or GIS data," said Amy Bunszel, Autodesk executive vice president of AEC Design Solutions. "This will improve efficiency and decision-making during planning, construction, and operations. Ultimately, our collaboration will help enable the industry to deliver more sustainable and resilient infrastructure."

AEC team members can track design, coordination, quality, safety, and commissioning issues by linking data from Autodesk BIM Collaborate with ArcGIS GeoBIM.

"What we need is a single, authoritative source of truth access point for everyone on our team, a way to bring data and information together that originates from multiple formats," said Darin Welch, HNTB associate vice president and national geospatial and virtual engagement manager. "Esri's ArcGIS GeoBIM connection to the Autodesk Construction Cloud combines survey, design, and planning workflows that offer a blended BIM-GIS data experience that equips our team with more informed decision-making."

ArcGIS GeoBIM is available for widespread use as of October 4, 2021. For more information and to stay up-to-date on the latest offerings, visit go.esri.com/geobim-pr .

About Esri

Esri, the global market leader in geographic information system (GIS) software, location intelligence, and mapping, helps customers unlock the full potential of data to improve operational and business results. Founded in 1969 in Redlands, California, USA, Esri software is deployed in more than 350,000 organizations globally and in over 200,000 institutions in the Americas, Asia and the Pacific, Europe, Africa, and the Middle East, including Fortune 500 companies, government agencies, nonprofits, and universities. Esri has regional offices, international distributors, and partners providing local support in over 100 countries on six continents. With its pioneering commitment to geospatial information technology, Esri engineers the most innovative solutions for digital transformation, the Internet of Things (IoT), and advanced analytics. Visit us at esri.com .

Copyright © 2021 Esri. All rights reserved. Esri, the Esri globe logo, ArcGIS, GeoBIM, The Science of Where, esri.com, and @esri.com are trademarks, service marks, or registered marks of Esri in the United States, the European Community, or certain other jurisdictions. Other companies and products or services mentioned herein may be trademarks, service marks, or registered marks of their respective mark owners.

Autodesk and Autodesk Construction Cloud are registered trademarks of Autodesk, Inc., in the USA and/or other countries .

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Echodyne Opens New Manufacturing Facility to Meet Surging Global Demand for Advanced MESA® Radar9.7.2026 15:00:00 CEST | Press release

New Washington State facility provides capacity to manufacture more than 30,000 radars annually, strengthening the U.S. defense industrial base As governments around the world accelerate investment in counter-unmanned aircraft systems (C-UAS) and short-range air defense, Echodyne today announced the opening of a new advanced radar manufacturing facility in Washington State, significantly expanding its manufacturing capacity to meet rapidly growing demand from U.S. and allied customers. With millions of drones manufactured and used by both sides in the Russian War in Ukraine, the need for enhanced safety for defense, national security, and critical infrastructure assets grows with every successful strike and interception. The low cost and high utility of drones dramatically alters the need for safety and security sensors. And as the low altitude economy takes off, hundreds of thousands of drones will perform a range of life-saving and commercial missions, requiring a sensor infrastructu

Orca Security Report: 99.9% of Fixable AI Vulnerabilities Remain Unpatched as AI Moves Into Production9.7.2026 15:00:00 CEST | Press release

Analysis of more than 1,200 production cloud environments provides a first-hand view into how organizations are embedding AI into business-critical workflows, exposing new security risks that traditional controls weren't built to address. Orca Security, a leader in cloud and AI security, today released its 2026 State of AI Security Report, offering a first-hand view into how AI is being deployed across more than 1,200 production cloud environments. The findings show AI is no longer limited to isolated pilots or developer experiments. Organizations are embedding AI into production applications, cloud services, and autonomous workflows faster than security programs can adapt. More than half (56%) of organizations have already deployed AI agents into production, while 51% use AI to build custom applications. At the same time, Orca found that 81% of organizations run vulnerable AI packages, and 99.9% of fixable AI vulnerabilities remain unpatched, highlighting how quickly AI has become ope

Viz.ai Expands into Neurodegenerative Disease with Cortechs.ai Collaboration9.7.2026 15:00:00 CEST | Press release

Cortechs.ai and Viz.ai partner to tackle multiple sclerosis and other neurodegenerative diseases across Viz.ai's health system network Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced a collaboration with Cortechs.ai, a global leader in neuroimaging and quantitative analysis solutions, to integrate Cortechs.ai's NeuroQuant and NeuroQuant MS suite into the Viz.ai platform, expanding access to quantitative neuroimaging for hospitals and health systems across the U.S. This partnership marks Viz.ai's expansion into neurodegenerative disease, growing Viz Neuro Suite beyond its already market-leading neuro offerings. The collaboration will begin with a focus on multiple sclerosis (MS), integrating quantitative MRI analysis from NeuroQuant MS directly into Viz.ai's care coordination workflow, giving clinicians both the quantitative precision and the coordination infrastructure needed to identify and manage MS patients at scale. “Viz.ai's co

SCP Standard Capital Partners AG: Fabian Becker Appointed Chairman of the Management Board and CEO9.7.2026 14:51:00 CEST | Press release

The Supervisory Board of SCP Standard Capital Partners AG (WKN: A12UPJ | ISIN: DE000A12UPJ7 | XETRA ticker: CAP) resolved today to appoint Mr. Fabian Becker as Chairman of the Management Board and Chief Executive Officer (CEO), effective as of 9 July 2026. Ms. Stephanie Schettler-Köhler will remain a member of the Management Board and will assume the role of Chief Operating Officer (COO). View source version on businesswire.com: https://www.businesswire.com/news/home/20260709982268/en/

Teva and Polpharma Biologics Announce Global Licensing Agreement for a Biosimilar Candidate to Ocrevus® (ocrelizumab) for Multiple Sclerosis9.7.2026 14:45:00 CEST | Press release

Teva secures exclusive global rights to commercialize Polpharma Biologics’ biosimilar candidate to Ocrevus® (ocrelizumab), including both intravenous and subcutaneous formulations.Agreement advances Teva’s Pivot to Growth strategy by expanding its biosimilars pipeline through strategic collaborations.Agreement reflects both companies’ commitment to broadening access to biologic medicines. Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd (NYSE: and TASE: TEVA) and Polpharma Biologics International AG today announced a global licensing agreement granting Teva exclusive rights to commercialize both formulations of Polpharma Biologics’ proposed biosimilar to Ocrevus®1 (ocrelizumab), upon regulatory approval. This strategic agreement is expected to combine Polpharma Biologics’ proven biosimilar development expertise with Teva’s commercial footprint and capabilities. This press release features multimedia. View the full release here: https://www.bus

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye